Parvani & Alaji ↔ Phlyctenular Conjunctivitis and Epibulbar Nodules

Parvani and Alaji's texture-colour-vascularity distinction maps reasonably well onto the clinical spectrum of phlyctenular disease severity, and both frameworks agree that treating the underlying lid-margin disease, not just the nodule, is what prevents recurrence. Their classical siting under Sandhigata Roga (canthal) sits awkwardly against phlyctenular disease's characteristically limbal location — a mismatch the source material names directly rather than resolving.

IN PLAIN LANGUAGE

Parvani and Alaji are two small nodules that can appear near the corner of the eye or its white part. Parvani is firmer, paler and less bothersome; Alaji is redder, softer, bleeds easily on contact and is more irritating. Their modern counterpart is phlyctenular conjunctivitis, an allergic-type reaction usually to bacteria living on the eyelids, most common in children with less-than-ideal lid hygiene.

Ayurveda offers dosha-matched local treatment and specifically emphasises treating the underlying lid-margin inflammation driving recurrence. Modern medicine offers a specific combination antibiotic-steroid treatment, and actively monitors for corneal spread and for look-alike conditions, including tumours, that need a different treatment altogether.

WHEN TO SEEK CARE

See an eye doctor if the lump is enlarging, appears in an older adult, is pigmented, or is not improving with standard treatment — these need to be checked for a growth rather than assumed benign. Seek urgent care if the lump seems to be spreading onto the coloured part of the eye or vision is affected, since this risks permanent scarring.

🔴 REFER IMMEDIATELY

The nodule enlarging onto or toward the cornea (risk of scarring and blood vessel growth on the cornea)
An enlarging, unilateral (especially in an older adult), pigmented, or non-resolving nodule
Recurrent episodes with poor response to standard anti-inflammatory treatment
Any corneal extension of the nodule
Any atypical feature suggesting a growth rather than an inflammatory nodule
Recurrent episodes not responding to standard treatment

Never do this

Do not treat an enlarging, fixed, pigmented, or non-resolving nodular lesion as routine Parvani, Alaji, or phlyctenular disease without imaging or biopsy to exclude a limbal growth. Do not continue local anti-inflammatory therapy alone once corneal extension is identified without escalating management.

🟢 SUITABLE FOR ROUTINE / COLLABORATIVE CARE

AYURVEDA SCOPE

Lekhana-type local measures for a firmer, Parvani-type nodule and cooling Aschyotana for a more vascular, Alaji-type nodule, in an isolated, non-recurrent, non-corneal-involving presentation, alongside treatment of any underlying chronic blepharitis.

MODERN MEDICINE SCOPE

Topical antibiotic-steroid combination therapy for phlyctenular disease, treatment of underlying staphylococcal blepharitis, and an imaging/biopsy pathway for atypical or neoplasia-suspicious lesions.

COLLABORATIVE SCOPE

Agreeing that underlying lid-margin disease (blepharitis) must be treated concurrently or the nodule is expected to recur; and deferring to biopsy or specialist referral once a lesion looks atypical, rather than treating it as routine Parvani, Alaji, or phlyctenular disease.

Sign in to read the full comparison

The plain-language summary and safety guidance above are free for everyone. The 10-dimension scholarly comparison needs an account.